NPCE
NeuroPace, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.90
+1.02%Margins
Gross margin
79.6%
EBITDA margin
-12.4%
EBIT margin
-15.3%
Net margin
-19.3%
FCF margin
-11.7%
-160.9%
Return on equity
-19.7%
Return on assets
-18.4%
Return on invested capital
1.01x
Asset turnover
-$11.2M
Cash from operations
$1.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026